Reflections on Travel to Europe – Part One
U.S. FDA
by
2d ago
Biologics, Drugs, Food & Beverages, Medical Devices, Tobacco ..read more
Visit website
Reflections on Travel to Europe – Part Two
U.S. FDA
by
2d ago
Biologics, Drugs, Food & Beverages, Medical Devices, Tobacco ..read more
Visit website
Reflections on Travel to Europe – Part Three
U.S. FDA
by
2d ago
Biologics, Drugs, Food & Beverages, Medical Devices, Tobacco ..read more
Visit website
Harnessing the Potential of Artificial Intelligence
U.S. FDA
by
1M ago
Animal & Veterinary, Biologics, Cosmetics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices, Radiation-Emitting Products, Tobacco ..read more
Visit website
FDA Helps to Deliver Meaningful Advances for Rare Disease Patients
U.S. FDA
by
1M ago
We remain committed to supporting rare disease research, engaging patients and caregivers to understand their unique perspectives, and enhancing our review processes to advance medical products for rare disease patients ..read more
Visit website
FDA Science, Research, and Collaboration Advance Generic Medicines
U.S. FDA
by
2M ago
In 2023, GDUFA-funded research helped expand our understanding of generic drug products, including complex products, and contributed to the development of advanced methods to characterize product quality and performance ..read more
Visit website
FDA Enhances Global Patient and Regulatory Collaborations in Oncology
U.S. FDA
by
2M ago
In recognition of World Cancer Day 2024, the FDA and European Medicines Agency will collaborate to spotlight innovative cancer treatment advances for patients ..read more
Visit website
FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
U.S. FDA
by
3M ago
FDA’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives ..read more
Visit website
Increasing Options in Clinical Research to Facilitate Medical Product Development
U.S. FDA
by
4M ago
FDA issued a final rule to help advance medical product development without compromising the rights, safety and welfare of people participating in clinical research ..read more
Visit website
Realizing the Promise of Real-World Evidence
U.S. FDA
by
4M ago
Realizing the full potential of RWE in regulatory decision-making presents several challenges, and work is underway at the FDA to better understand this area ..read more
Visit website

Follow U.S. FDA on FeedSpot

Continue with Google
Continue with Apple
OR